FTXH vs. FDL
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and FDL (First Trust Morningstar Dividend Leaders Index Fund) are both exchange-traded funds - FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index, while FDL is a Large Cap Value Equities fund tracking the Morningstar Dividend Leaders Index. Both are passively managed. Over the past 5 years, FTXH returned 8.33%/yr vs 12.69%/yr for FDL. A 0.51 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.45%/yr for FDL.
Performance
FTXH vs. FDL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 7.62% return, which is significantly lower than FDL's 14.21% return.
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
FDL
- 1D
- 0.78%
- 1M
- 0.32%
- YTD
- 14.21%
- 6M
- 15.52%
- 1Y
- 25.50%
- 3Y*
- 19.57%
- 5Y*
- 12.69%
- 10Y*
- 11.28%
FTXH vs. FDL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
FDL First Trust Morningstar Dividend Leaders Index Fund | 14.21% | 14.79% | 17.98% | 2.94% | 6.66% | 26.10% | -4.30% | 24.41% | -5.99% | 12.02% |
Correlation
The correlation between FTXH and FDL is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2016 | 0.51 |
The correlation between FTXH and FDL shifts across timeframes, from 0.47 (1 year) to 0.61 (5 years), reflecting how their relationship changes across market environments.
FTXH vs. FDL - Sectors Allocation Comparison
Sectors
FTXH
FDL
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
FTXH
FDL
Basic Materials
FTXH
-
FDL
Communication Services
FTXH
-
FDL
Consumer Cyclical
FTXH
-
FDL
Consumer Defensive
FTXH
-
FDL
Energy
FTXH
-
FDL
Financial Services
FTXH
-
FDL
Industrials
FTXH
-
FDL
Real Estate
FTXH
-
FDL
-
Technology
FTXH
-
FDL
Utilities
FTXH
-
FDL
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. FDL — Risk / Return Rank
FTXH
FDL
FTXH vs. FDL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust Morningstar Dividend Leaders Index Fund (FDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTXH | FDL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.09 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.40 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 5.32 | 5.99 | -0.68 |
| Martin ratioReturn relative to average drawdown | 15.35 | 14.59 | +0.76 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FTXH | FDL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.32 | 2.27 | +0.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.89 | -0.38 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.66 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.45 | -0.06 |
Drawdowns
FTXH vs. FDL - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum FDL drawdown of -65.93%. Use the drawdown chart below to compare losses from any high point for FTXH and FDL.
Loading charts...
Drawdown Indicators
| FTXH | FDL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -65.93% | +33.82% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -4.27% | -3.20% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -12.24% | -7.27% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -16.46% | -3.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -41.40% | — |
Current DrawdownCurrent decline from peak | -0.45% | -1.41% | +0.96% |
Average DrawdownAverage peak-to-trough decline | -5.84% | -9.66% | +3.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 1.75% | +0.83% |
Volatility
FTXH vs. FDL - Volatility Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 5.38% compared to First Trust Morningstar Dividend Leaders Index Fund (FDL) at 2.95%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than FDL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | FDL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.38% | 2.95% | +2.43% |
Volatility (6M)Calculated over the trailing 6-month period | 11.96% | 7.85% | +4.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.14% | 11.30% | +5.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.34% | 14.31% | +2.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.43% | 17.11% | +1.32% |
FTXH vs. FDL - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than FDL's 0.45% expense ratio.
Dividends
FTXH vs. FDL - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.19%, less than FDL's 3.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FDL First Trust Morningstar Dividend Leaders Index Fund | 3.65% | 4.04% | 4.96% | 4.58% | 3.58% | 4.59% | 4.48% | 3.75% | 3.97% | 3.18% | 2.93% | 3.65% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
Frequently Asked Questions
FTXH and FDL have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FTXH has higher volatility (5.38%) compared to FDL (2.95%). In terms of maximum drawdown, FTXH dropped -32.11% vs FDL's -65.93%.
On 5-year performance, FDL leads with 12.69% vs 8.33% for FTXH. On fees, FDL is cheaper at 0.45% per year. On volatility, FDL has been the lower-risk option at 2.95%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FDL has performed better with a 12.69% return vs 8.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FDL is cheaper with a 0.45% expense ratio, compared with 0.60% for FTXH.
FDL has the higher dividend yield at 3.65%, compared with 1.19% for FTXH.
FTXH is categorized as Health & Biotech Equities, while FDL is Large Cap Value Equities. FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while FDL tracks Morningstar Dividend Leaders Index. Their fees differ too: 0.60% for FTXH and 0.45% for FDL.
FTXH currently has the higher Sharpe Ratio (2.32 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and FDL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer